The deep socio-cultural and normative changes, the progressive lengthening of life and the increase in the incidence of chronical desease, have generated strong repercussions on the entire pharma industry.
Moreover, the coming of digital and the multiplication of touch points has changed the competitive balance among companies and the way they get in contact with patients / consumers: on the one hand the patient is increasingly informed and active in the management of his care path, from the other the stakeholder chain is no longer exclusively focused on doctor, but it is longer and diversified.
All these elements highlight the need for greater attention to the patient and to the whole constellation of his influencers.
Our team has gained significant expertise in the sector, both nationally and internationally, carrying out research on all the subjects involved in the treatment path (doctors, patients, pharmacists, representative, caregivers, influencers), in different product categories (OTC, ethical medication and medical device) in several specialist fields (dermatology, diabetology, gastroenterology and oncology).
Development of an ad-hoc research project aimed at promoting patient involvement in care pathways
Exploration of the meanings and psychological implications about drugs usage, patient-doctor relationship, attitudes and perceptions about health and disease
Analysis of patient’s decision making process concerning care pathways and his relationships with brands
Brand image, reputation and trust analysis, both for patients and stakeholders
